Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Rivaroxaban (Xarelto®)
Rivaroxaban (Xarelto®)
NICE TA 287. Guidance in development. Rivaroxaban is green for the initial dose for this indication in line with the primary care DVT pathway.
- Traffic Light
Amber (G)
- BNF
2.8.2
- Licensed Indicators
Treatment of PE and preventing DVT and PE in adults.
- Reference
APC Aug 12,Nov 12, July 13 and June 14
- Criteria
- Provisional
No
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik